<http://webisa.webdatacommons.org/43915428>	<http://www.w3.org/ns/prov#value>	"eceipt of potential milestones and royalties under our collaborative agreements, government regulations, reliance on third parties to conduct clinical trials and perform research and analysis services, adequate financial resources, changes in economic and business conditions, and other factors relating to our growth." .
<http://webisa.webdatacommons.org/prov/132467020>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/43915428> .
<http://webisa.webdatacommons.org/43915428>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/43915428>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<sec.gov> .